Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine plus Prednisone for Autoimmune Hepatitis
NCT02463331Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- May 2003
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of chloroquine in autoimmune hepatitis (AIH) (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Biochemical Response to Therapy at 6 months. Started May 2003; status: completed.
02
Drugs
chloroquine
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT02463331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02463331.